Peter Walter is a renowned scientist and researcher who has made significant contributions to molecular biology. He is now a co-founder and scientific advisor at Altos Labs, a biotech startup specializing in aging research and rejuvenation.
Walter started his career as a postdoctoral researcher at the University of California, San Francisco, studying protein synthesis and trafficking. He later joined the faculty at the University of California, Berkeley, where he made several important discoveries about protein folding and quality control in cells.
Walter has been a pioneer in biotech entrepreneurship in addition to his academic research. He co-founded Cellzome, a biotech company that developed drug discovery technologies and was later acquired by GlaxoSmithKline. He also co-founded Bolt Biotherapeutics, a biotech company that is developing new cancer treatments.
In 2021, Walter co-founded Altos Labs, a biotech startup focused on aging research and rejuvenation. The company is dedicated to exploring new approaches to extending the human lifespan and improving healthspan and has attracted significant attention from investors and the media.
Walter’s research and entrepreneurial endeavors have earned him numerous awards and honors, including the Breakthrough Prize in Life Sciences, the Lasker-DeBakey Clinical Medical Research Award, and the Shaw Prize in Life Science and Medicine. His work at Altos Labs is helping to push the boundaries of aging research and could have significant implications for human health and longevity in the future.